Materials and methods for inhibition of respiratory syncytial virus infection
CA 2484251 C · Owner: Behera, Aruna K. · Inventors: Behera, Aruna K.; Mohapatra, Shyam S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The subject invention concerns a method of inhibiting an RNA virus infection within a patient by increasing the amount of 2-5 oligoadenylate (2-5 AS) activity within the patient. Preferably the preventive and therapeutic , methods of the present invention involve administering a nucleotide encoding 2- 5 AS, or at least one catalytically active fragment thereof such as the p40, p69, p100 subunits to a patient in need thereof. The present inventors have determined that overexpression of 2-5AS causes a reduction in epithelial cell damage, reduction in infiltration of mononuclear cells in the peribronchiolar and perivascular regions, and reduction in thickening of the septa in the lungs. …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 30, 2003 and granted June 23, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 30, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 30, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.